$XRAY
DENTSPLY SIRONA Inc. Stock $xray

$xray Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000081847924000036 Filed on May 02, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$984.0M	$953.0M
YoY Change	-4.28%	-2.56%
Cost Of Revenue	$473.0M	$447.0M
YoY Change	-1.05%	-2.61%
Gross Profit	$511.0M	$506.0M
YoY Change	-7.09%	-2.5%
Gross Profit Margin	51.93%	53.1%
Selling, General & Admin	$399.0M	$415.0M
YoY Change	-4.09%	-0.24%
% of Gross Profit	78.08%	82.02%
Research & Development	$41.00M	$42.00M
YoY Change	-16.33%	-8.7%
% of Gross Profit	8.02%	8.3%
Depreciation & Amortization	$86.00M	$32.00M
YoY Change	0.0%	3.23%
% of Gross Profit	16.83%	6.32%
Operating Expenses	$440.0M	$457.0M
YoY Change	-5.38%	-1.08%
Operating Profit	$50.00M	$42.00M
YoY Change	-41.18%	-2200.0%
Interest Expense	-$21.00M	$18.00M
YoY Change	0.0%	-5.26%
% of Operating Profit	-42.0%	42.86%
Other Income/Expense, Net	$1.000M	$7.000M
YoY Change	-107.69%	-200.0%
Pretax Income	$34.00M	$31.00M
YoY Change	-26.09%	-210.71%
Income Tax	$38.00M	$14.00M
% Of Pretax Income	111.76%	45.16%
Net Earnings	-$4.000M	$18.00M
YoY Change	-104.65%	-194.74%
Net Earnings / Revenue	-0.41%	1.89%
Basic Earnings Per Share	-$0.02	$0.09
Diluted Earnings Per Share	-$0.02	$0.09
COMMON SHARES
Basic Shares Outstanding	207.6M shares	207.4M shares
Diluted Shares Outstanding	205.6M shares	208.5M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$279.0M	$291.0M
YoY Change	-5.42%	-8.49%
Cash & Equivalents	$279.0M	$291.0M
Short-Term Investments
Other Short-Term Assets	$280.0M	$342.0M
YoY Change	-6.04%	8.92%
Inventory	$608.0M	$613.0M
Prepaid Expenses
Receivables	$591.0M	$656.0M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.758B	$1.902B
YoY Change	-8.44%	-2.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$789.0M	$782.0M
YoY Change	-18.07%	1.56%
Goodwill	$2.389B	$2.400B
YoY Change	-11.62%	-11.14%
Intangibles	$1.559B	$1.618B
YoY Change	-13.77%	-13.1%
Long-Term Investments
YoY Change
Other Assets	$240.0M	$250.0M
YoY Change	-6.25%	21.36%
Total Long-Term Assets	$5.139B	$5.221B
YoY Change	-10.31%	-8.88%
TOTAL ASSETS
Total Short-Term Assets	$1.758B	$1.902B
Total Long-Term Assets	$5.139B	$5.221B
Total Assets	$6.897B	$7.123B
YoY Change	-9.84%	-7.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$287.0M	$279.0M
YoY Change	8.3%	4.49%
Accrued Expenses	$650.0M	$681.0M
YoY Change	-10.71%	-8.96%
Deferred Revenue	$105.0M	$102.0M
YoY Change	-5.41%	9.68%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$362.0M	$343.0M
YoY Change	38.7%	8.54%
Total Short-Term Liabilities	$1.323B	$1.330B
YoY Change	4.09%	-3.2%
LONG-TERM LIABILITIES
Long-Term Debt	$1.737B	$1.747B
YoY Change	-5.65%	-5.16%
Other Long-Term Liabilities	$466.0M	$454.0M
YoY Change	-18.96%	12.38%
Total Long-Term Liabilities	$2.203B	$2.201B
YoY Change	-8.82%	-2.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.323B	$1.330B
Total Long-Term Liabilities	$2.203B	$2.201B
Total Liabilities	$3.833B	$3.865B
YoY Change	-2.91%	-4.21%
SHAREHOLDERS EQUITY
Retained Earnings	$152.0M	$190.0M
YoY Change	-67.17%	-53.32%
Common Stock	$3.000M	$3.000M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.064B	$3.258B
YoY Change
Total Liabilities & Shareholders Equity	$6.897B	$7.123B
YoY Change	-9.84%	-7.17%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$4.000M	$18.00M
YoY Change	-104.65%	-194.74%
Depreciation, Depletion And Amortization	$86.00M	$32.00M
YoY Change	0.0%	3.23%
Cash From Operating Activities	$208.0M	$25.00M
YoY Change	100.0%	-219.05%
INVESTING ACTIVITIES
Capital Expenditures	$52.00M	$34.00M
YoY Change	57.58%	-12.82%
Acquisitions
YoY Change
Other Investing Activities	$2.000M	-$9.000M
YoY Change	-33.33%	-550.0%
Cash From Investing Activities	-$50.00M	-$43.00M
YoY Change	66.67%	16.22%
FINANCING ACTIVITIES
Cash Dividend Paid		$29.00M
YoY Change		7.41%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$3.000M
YoY Change
Cash From Financing Activities	-171.0M	-$14.00M
YoY Change	96.55%	-182.35%
NET CHANGE
Cash From Operating Activities	208.0M	$25.00M
Cash From Investing Activities	-50.00M	-$43.00M
Cash From Financing Activities	-171.0M	-$14.00M
Net Change In Cash	-13.00M	-$43.00M
YoY Change	0.0%	-8.51%
FREE CASH FLOW
Cash From Operating Activities	$208.0M	$25.00M
Capital Expenditures	$52.00M	$34.00M
Free Cash Flow	$156.0M	-$9.000M
YoY Change	119.72%	-85.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
CY2024Q1	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent
CY2023Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2024Q1	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	447000000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	459000000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	506000000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	519000000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	415000000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	416000000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	42000000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	46000000	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	6000000	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2024Q1	us-gaap	Restructuring Charges RestructuringCharges	1000000	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	59000000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	42000000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2000000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	18000000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	20000000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7000000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6000000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	31000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	17000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-23000000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1000000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	18000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-19000000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	207400000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	214500000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	208500000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	214500000	shares
CY2024Q1	us-gaap	Profit Loss ProfitLoss	17000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-23000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-62000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	15000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	32000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-1000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-30000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	14000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-13000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-9000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-4000000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12000000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5000000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	291000000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	334000000	usd
CY2024Q1	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	656000000	usd
CY2023Q4	us-gaap	Accounts Notes And Loans Receivable Net Current AccountsNotesAndLoansReceivableNetCurrent	695000000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	613000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	624000000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	342000000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	320000000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	1902000000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1973000000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	782000000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	800000000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	171000000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	178000000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1618000000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1705000000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	2400000000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	2438000000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	250000000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	276000000	usd
CY2024Q1	us-gaap	Assets Assets	7123000000	usd
CY2023Q4	us-gaap	Assets Assets	7370000000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	279000000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	305000000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	681000000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	749000000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	27000000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	49000000	usd
CY2024Q1	us-gaap	Debt Current DebtCurrent	343000000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	322000000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1330000000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1425000000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1747000000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1796000000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	120000000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	125000000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	214000000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	228000000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	454000000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	502000000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	3865000000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4076000000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	250000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	250000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	3000000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3000000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000.0	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000.0	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	264500000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	264500000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	207600000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	207200000	shares
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6639000000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6643000000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	190000000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	205000000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-666000000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-636000000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	56900000	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	57300000	shares
CY2024Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2908000000	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2922000000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	3258000000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3293000000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	0	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	1000000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3258000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3294000000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7123000000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7370000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3294000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	17000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-30000000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11000000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	3000000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-4000000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.16
CY2024Q1	us-gaap	Dividends Cash DividendsCash	33000000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3258000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3812000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-23000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	14000000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17000000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	3000000	usd
CY2023Q1	us-gaap	Accelerated Share Repurchase Program Adjustment AcceleratedShareRepurchaseProgramAdjustment	-151000000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-4000000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.14
CY2023Q1	us-gaap	Dividends Cash DividendsCash	30000000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3638000000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	17000000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-23000000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	32000000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	31000000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	54000000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	53000000	usd
CY2024Q1	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0	usd
CY2023Q1	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	4000000	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	6000000	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9000000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-21000000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11000000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	17000000	usd
CY2024Q1	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2023Q1	us-gaap	Restructuring Costs RestructuringCosts	48000000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-19000000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-9000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-27000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	15000000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5000000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	30000000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	28000000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	17000000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	6000000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-28000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-14000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-50000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-31000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-2000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-37000000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-13000000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	6000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	25000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21000000	usd
CY2024Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	34000000	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	39000000	usd
CY2024Q1	us-gaap	Proceeds From Derivative Instrument Investing Activities ProceedsFromDerivativeInstrumentInvestingActivities	0	usd
CY2023Q1	us-gaap	Proceeds From Derivative Instrument Investing Activities ProceedsFromDerivativeInstrumentInvestingActivities	2000000	usd
CY2024Q1	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	9000000	usd
CY2023Q1	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-43000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37000000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	150000000	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	23000000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	198000000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	29000000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	27000000	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3000000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-5000000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-4000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-14000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17000000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-11000000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-43000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-47000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	334000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	365000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	291000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	318000000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of Net sales and expense during the reporting period. Actual results could differ materially from those estimates.</span></div>
CY2024Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	8000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	38000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-30000000	usd
CY2024Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	5000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-9000000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	953000000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	978000000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	953000000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	978000000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	102000000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	59000000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	91000000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	57000000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	41000000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	17000000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	17000000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11000000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17000000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2000000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	14000000	usd
CY2023Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	14000000	usd
CY2024Q1	us-gaap	Aoci Including Portion Attributable To Noncontrolling Interest Tax AociIncludingPortionAttributableToNoncontrollingInterestTax	128000000	usd
CY2023Q4	us-gaap	Aoci Including Portion Attributable To Noncontrolling Interest Tax AociIncludingPortionAttributableToNoncontrollingInterestTax	166000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	18000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-19000000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	207400000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	214500000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	18000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-19000000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	207400000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	214500000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1100000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	208500000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	214500000	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2024Q1	xray	Weighted Average Number Of Shares Excluded From Computation Of Earnings Per Share Due To Net Loss WeightedAverageNumberOfSharesExcludedFromComputationOfEarningsPerShareDueToNetLoss	0	shares
CY2023Q1	xray	Weighted Average Number Of Shares Excluded From Computation Of Earnings Per Share Due To Net Loss WeightedAverageNumberOfSharesExcludedFromComputationOfEarningsPerShareDueToNetLoss	1400000	shares
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3300000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3800000	shares
CY2023Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	1000000000	usd
CY2024Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	1440000000	usd
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	segment
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	31000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-28000000	usd
CY2024Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	174000000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	185000000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	75000000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	77000000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	364000000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	362000000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	613000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	624000000	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	107000000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	107000000	usd
CY2024Q1	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	4000000	usd
CY2023Q1	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	63000000	usd
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	segment
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	40000000	usd
CY2024Q1	xray	Restructuring Reserve Previous And Current Accrual Adjustments RestructuringReservePreviousAndCurrentAccrualAdjustments	4000000	usd
CY2024Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	12000000	usd
CY2024Q1	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-2000000	usd
CY2024Q1	us-gaap	Restructuring Reserve RestructuringReserve	30000000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	447000000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	18000000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7000000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	459000000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	20000000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6000000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	21000000	usd
CY2024Q1	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2024Q1	us-gaap	Derivative Assets DerivativeAssets	21000000	usd
CY2024Q1	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	13000000	usd
CY2024Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	8000000	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	38000000	usd
CY2024Q1	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	38000000	usd
CY2024Q1	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	13000000	usd
CY2024Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	25000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	16000000	usd
CY2023Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	16000000	usd
CY2023Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	9000000	usd
CY2023Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	7000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	84000000	usd
CY2023Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	84000000	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	9000000	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	75000000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.449
CY2024Q1	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	185000000	usd
CY2024Q1	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	104000000	usd
CY2024Q1	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	51000000	usd
CY2024Q1	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	29000000	usd
CY2024Q1	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	32000000	usd
CY2024Q1	xray	Purchase Obligation To Be Paid After Fourth Year PurchaseObligationToBePaidAfterFourthYear	0	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.184
CY2024Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	19000000	usd
CY2024Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.056
CY2024Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	475000000	usd
CY2023Q4	us-gaap	Goodwill Gross GoodwillGross	2729000000	usd
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	291000000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	2438000000	usd
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-38000000	usd
CY2024Q1	us-gaap	Goodwill Gross GoodwillGross	2400000000	usd
CY2024Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2024Q1	us-gaap	Goodwill Goodwill	2400000000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3017000000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1832000000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1185000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3068000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1815000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1253000000	usd
CY2024Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	433000000	usd
CY2024Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	433000000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	452000000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	452000000	usd
CY2024Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3450000000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1832000000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1618000000	usd
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3520000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1815000000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1705000000	usd
CY2018Q3	xray	Loss Contingency Number Of Distributors Allegedly Engaged In Anticompetitive Conduct LossContingencyNumberOfDistributorsAllegedlyEngagedInAnticompetitiveConduct	3	distributor
CY2016	us-gaap	General Partner Distributions GeneralPartnerDistributions	451000000	usd
CY2016	xray	Additional Federal Income Taxes Excluding Interest AdditionalFederalIncomeTaxesExcludingInterest	2000000	usd
CY2024Q1	us-gaap	Purchase Obligation PurchaseObligation	401000000	usd
CY2024Q1	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	98000000	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000818479-24-000036-index-headers.html	Edgar Link	pending
0000818479-24-000036-index.html	Edgar Link	pending
0000818479-24-000036.txt	Edgar Link	pending
0000818479-24-000036-xbrl.zip	Edgar Link	pending
exhibit311q12024.htm	Edgar Link	pending
exhibit312q12024.htm	Edgar Link	pending
exhibit32q12024.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xray-20240331.htm	Edgar Link	pending
xray-20240331.xsd	Edgar Link	pending
xray-20240331_def.xml	Edgar Link	unprocessable
xray-20240331_pre.xml	Edgar Link	unprocessable
xray-20240331_lab.xml	Edgar Link	unprocessable
xray-20240331_htm.xml	Edgar Link	completed
xray-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XRAY
DENTSPLY SIRONA Inc. Stock $xray

2024 Q2 Form 10-Q Financial Statement

#000081847924000036 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XRAY DENTSPLY SIRONA Inc. Stock $xray

2024 Q2 Form 10-Q Financial Statement

#000081847924000036 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XRAY
DENTSPLY SIRONA Inc. Stock $xray